123 related articles for article (PubMed ID: 6297868)
1. [Tumor markers in C-cell cancer].
Raue F; Schmidt-Gayk H; Ziegler R
Dtsch Med Wochenschr; 1983 Feb; 108(8):283-7. PubMed ID: 6297868
[TBL] [Abstract][Full Text] [Related]
2. Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of the thyroid.
Calmettes C; Moudktar MS; Milhaud G
Biomedicine; 1977 Mar; 27(2):52-4. PubMed ID: 861349
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
[TBL] [Abstract][Full Text] [Related]
4. Roles of circulating carcinoembryonic antigen and calcitonin in diagnosis of medullary thyroid carcinoma: a comparative study.
Hamada S; Ishikawa N; Yoshi M; Morita R; Fukunaga M
Endocrinol Jpn; 1976 Dec; 23(6):505-10. PubMed ID: 1022524
[TBL] [Abstract][Full Text] [Related]
5. The detection of elevated plasma levels of carcinoembryonic antigen in patients with suspected or established medullary thyroid carcinoma.
Wells SA; Haagensen DE; Linehan WM; Farrell RE; Dilley WG
Cancer; 1978 Sep; 42(3 Suppl):1498-503. PubMed ID: 709521
[TBL] [Abstract][Full Text] [Related]
6. [Use of tumor markers in monitoring thyroid carcinoma].
Gorgone S; Lazzara S; Palmeri R; Belnome N; Calbo L; Dattola P; Melita P
Chir Ital; 1987 Feb; 39(1):87-95. PubMed ID: 3607983
[TBL] [Abstract][Full Text] [Related]
7. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
[TBL] [Abstract][Full Text] [Related]
8. Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma.
Busnardo B; Girelli ME; Simioni N; Nacamulli D; Busetto E
Cancer; 1984 Jan; 53(2):278-85. PubMed ID: 6690009
[TBL] [Abstract][Full Text] [Related]
9. Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times.
Laure Giraudet A; Al Ghulzan A; Aupérin A; Leboulleux S; Chehboun A; Troalen F; Dromain C; Lumbroso J; Baudin E; Schlumberger M
Eur J Endocrinol; 2008 Feb; 158(2):239-46. PubMed ID: 18230832
[TBL] [Abstract][Full Text] [Related]
10. Plasma calcitonin and ACTH responses to lysine vasopressin, calcium and pentagastrin in a patient with medullary thyroid carcinoma associated with Cushing's syndrome.
Shimatsu A; Kato Y; Tanaka I; Nakai Y; Fukunaga M; Imura H
Clin Endocrinol (Oxf); 1983 Feb; 18(2):119-25. PubMed ID: 6133658
[TBL] [Abstract][Full Text] [Related]
11. [Tumours markers. Calcitonin and carcinoembryonic antigen in medullary carcinoma of the thyroid (author's transl)].
Calmettes C; Moukhtar MS; Milhaud G
Presse Med (1893); 1979 Dec; 8(48):3947-50. PubMed ID: 530945
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique.
Talerman A; Lindeman J; Kievit-Tyson PA; Dröge-Droppert C
Histopathology; 1979 Nov; 3(6):503-10. PubMed ID: 389771
[TBL] [Abstract][Full Text] [Related]
13. Serum tissue polypeptide antigen (TPA) in thyroid cancer.
Martino E; Bambini G; Aghini-Lombardi F; Motz E; Pacini F; Lari R; Baschieri L; Pinchera A
J Endocrinol Invest; 1984 Jun; 7(3):249-52. PubMed ID: 6547969
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
[TBL] [Abstract][Full Text] [Related]
15. Tissue polypeptide antigen and carcinoembryonic antigen as tumor markers in lung cancer.
Lee YC; Yang PC; Kuo SH; Luh KT
J Formos Med Assoc; 1991 Jul; 90(7):631-6. PubMed ID: 1681012
[TBL] [Abstract][Full Text] [Related]
16. Localization and resection of clinically inapparent medullary carcinoma of the thyroid.
Norton JA; Doppman JL; Brennan MF
Surgery; 1980 Jun; 87(6):616-22. PubMed ID: 7376073
[TBL] [Abstract][Full Text] [Related]
17. Disparity between tissue and serum calcitonin and carcinoembryonic antigen in a patient with medullary thyroid carcinoma.
Alapat DV; Ain KB; Sloan DA; Monaghan KG; Karabakhtsian RG
Endocrine; 2011 Apr; 39(2):148-52. PubMed ID: 21243446
[TBL] [Abstract][Full Text] [Related]
18. Humoral markers for thyroid carcinoma.
Pacini F; Martino E; Bambini G; Aghini-Lombardi F; Taddei D; Lari R; Pinchera A; Baschieri L
Cancer Detect Prev; 1985; 8(1-2):17-22. PubMed ID: 4064037
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
Barbet J; Campion L; Kraeber-Bodéré F; Chatal JF;
J Clin Endocrinol Metab; 2005 Nov; 90(11):6077-84. PubMed ID: 16091497
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin and carcino-embryonic antigen in the follow-up of patients with medullary carcinoma of the thyroid.
Palmer BV; Harmer CL; Shaw HJ
Br J Surg; 1984 Feb; 71(2):101-4. PubMed ID: 6692098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
